Mercedes
Iñarrairaegui Bastarrica
Consultora Médica
Hospital Universitario Central de Asturias
Oviedo, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Central de Asturias (8)
2022
-
Decreased Long-Term Severe Acute Respiratory Syndrome Coronavirus 2–Specific Humoral Immunity in Liver Transplantation Recipients 12 Months After Coronavirus Disease 2019
Liver Transplantation, Vol. 28, Núm. 6, pp. 1039-1050
-
Nivolumab after selective internal radiation therapy for the treatment of hepatocellular carcinoma: a phase 2, single-arm study
Journal for immunotherapy of cancer, Vol. 10, Núm. 11
2021
-
Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients
American Journal of Transplantation, Vol. 21, Núm. 8, pp. 2876-2884
-
Corrigendum to “Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules” [J Hepatol (2019) 874–884] (Journal of Hepatology (2019) 70(5) (874–884), (S0168827819300157), (10.1016/j.jhep.2019.01.005))
Journal of Hepatology
-
Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients
Journal of Hepatology, Vol. 74, Núm. 1, pp. 148-155
2019
-
Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules
Journal of Hepatology, Vol. 70, Núm. 5, pp. 874-884
2017
2016
-
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
Journal of Hepatology, Vol. 65, Núm. 4, pp. 719-726